Cherry Hill Mortgage Investment Corporation (NYSE:CHMI) stated dividend of $0.49 per share

Cherry Hill Mortgage Investment Corporation (NYSE:CHMI) announced that its Board of Directors has declared a dividend of $0.49 per share on the Company’s common stock for the fourth quarter of 2016. The dividend will be payable in cash on January 31, 2017 to stockholders of record as of the close of business on December 31, 2016.

Cherry Hill Mortgage Investment Corporation (NYSE:CHMI) traded 35263 shares and was closed at $18.19 per share. The current share price indicates that stock is -0.63% away from its one year high and is moving 64.07% ahead of its one year low. Stock monthly performance is recorded as 6.33% while its performance in last 5 sessions is 0.97%.

Analyst’s Analysis on Cherry Hill Mortgage Investment Corporation (NYSE:CHMI)

At the movement stock is under coverage by number of analysts. 2 given Buy rating to the stock and 2 analysts given HOLD rating. The consensus recommendation by Thomson Reuters analysts is Outperform and their mean rating for the stock is 2.00 on scale of 1-5. Analysts mean target price for Cherry Hill Mortgage Investment Corporation (NYSE:CHMI) is $18.75 while their mean recommendation is 2.00 (1=Buy, 5=sell).

XOMA Corporation (NASDAQ:XOMA) shares moved to $4.22 after starting the day at $4.53 on Friday. Weekly volatility of XOMA is 8.34% and monthly volatility is 5.98%. Stock performance in last five sessions is recorded as -23.27% while year to date (YTD) performance is -84.14%. XOMA return on assets is -22.40%. Stock 3 months performance is recorded as -54.13%.

Analyst Rating on XOMA Corporation (NASDAQ:XOMA)

Number of analysts are covering this stock and currently 5 analysts given HOLD rating to the stock. Analyst’s mean target price for XOMA is $12.75 while analysts mean recommendation is 3.00.

Neurocrine Biosciences, Inc. (NASDAQ:NBIX) traded 835124 shares and was closed at $38.70 per share. The current share price indicate that stock is -33.00% away from its one year high and is moving 23.84% ahead of its one year low. Stock monthly performance is recorded as -16.68% while its performance in last 5 sessions is -0.87%.

Analyst’s Analysis on Neurocrine Biosciences, Inc. (NASDAQ:NBIX)

At the movement stock is under coverage by number of analysts. At the movement stock is under coverage by number of analysts. 4 given Buy rating to the stock and 1 analyst given HOLD rating. The consensus recommendation by Thomson Reuters analysts is Outperform and their mean rating for the stock is 1.75 on scale of 1-5. Analysts mean target price for Neurocrine Biosciences, Inc. (NASDAQ:NBIX) is $68.27 while their mean recommendation is 1.80 (1=Buy, 5=sell).

Masco Corporation (NYSE:MAS) announced that its Board of Directors declared a quarterly dividend of $.10 per common share, payable on February 13, 2017, to shareholders of record on January 13, 2017.

Masco Corporation (NYSE:MAS) shares moved to $31.62 after starting the day at $32.08 on Friday. Weekly volatility of MAS is 1.21% and monthly volatility is 1.89%. Stock performance in last five sessions is recorded as -1.28% while year to date (YTD) performance is 13.15%. MAS Gross Margin is 33.00% and its return on assets is 8.10%. Firm quarterly performance is -7.56%.

Analyst Recommendation on Masco Corporation (NYSE:MAS)

Number of analysts are covering this stock and currently stock has got OUTPERFORM rating from 8 analysts of Thomson Reuters, 7 analysts given HOLD rating to the stock. Analyst’s mean target price for MAS is $37.53 while analysts mean recommendation is 2.00.

Leave a Reply

Your email address will not be published. Required fields are marked *